Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Were you standing in front of a mirror (question asked). If not, should you be (question answered). Anyway, why don’t you share with us your public facing answer to your public facing amazement/query. Thanks, as always, LC.
>>At some point you really need to ask yourself...What the heck is this guy doing on a tiny cashless Bethesda biotech board?<<
Hmmm… really?? I think you don’t mean that, or I don’t understand it. Well, anyway, again, maybe there is a better platform to explain rationales for espousing such sentiment, as we discussed previously. I used Chat, and learned that in a civil case, plaintiffs can call witnesses to testify based on their relevance to the case and their potential to provide information or evidence that supports the plaintiff's claims. Through a certain lens, given your history here, experience in the “biotech game”, and other anomalies and patterns, well, arguably, the potential to provide information relative to plaintiffs case seems more likely than not. I don’t know.
35 years in the biotech game, you say? Impressive. What do attracts you to NWBO?
LC, what do you think, a 3rd party wanting to control NWBO? ?? Not sure it’s possible, tho. But, what do you think, with your decades in the “biotech game” experience, much of that spent here at IHub NWBO.
Yes, ex. People want to hear it from you. Own it. Why not start here.
….And we have people here (working on behalf of others, all of them for money) all trying to destroy this company, which is trying to treat/cure cancer…
Just sayin. LC is right, I don’t know.
The last paragraph first: copy n paste:
“Merck has become dependent on Keytruda for more than 40% of company sales and faces a revenue hit when Keytruda’s main U.S. patent expires in 2028.”
12:29 PM EDT, April 25, 2024 (Benzinga Newswire)
On Thursday, US drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8 billion, up 9% year-over-year, beating the consensus estimate of $15.2 billion.
Excluding the impact of foreign exchange, sales increased 24%.
Merck reported adjusted EPS of $2.07, up 48%Y/Y, beating the consensus of $1.88.
Merck’s pharmaceutical unit booked $14.01 billion in revenue during the first quarter, up 10% Y/Y.
Related: Merck’s $11B Bet Pays As FDA Approves Sotatercept For Rare Lung Disease.
Merck’s blockbuster cancer immunotherapy Keytruda largely drove the growth. Keytruda generated $6.95 billion in revenue during the quarter, up 20% from the year-earlier period.
Merck has become dependent on Keytruda for more than 40% of company sales and faces a revenue hit when Keytruda’s main U.S. patent expires in 2028.”….
Wow. 35 years in the bio game. A lot of knowledge you have. …
Questions. Posting oddities. Seems reasonable. Especially given the alleged spoofing. You project a very knowing persona. As you say, I don’t.
I wonder, does anyone pay attention to IHUB NWBO postings? In terms of, certain activities linked to other activities. Things, oddities, that really make people wonder, about correlation…
1. Anomalies linking points
2. Eccentricities correlating dots
3. Peculiarities joining the dots
4. Quirks tying together points
5. Aberrations bridging connections
Right? I wonder. That’s all. Yeah. Real questions. Thanks.
If it’s a subpoena, you’ll usually have to appear. Do you know if persons can be served to appear in Civil cases?
So you do think you’ll be asked real questions. Thanks. … LC, don’t worry, remember, you don’t HAVE to answer.
Do you think some will start asking real questions of you?
Interesting thought? IC?
Interesting post. IC?
Thank you. You have no idea how perfect it is.
… “Thus spoofing activities”… LC, perhaps you’ll, also, be called (subpoenaed) to testify. You have much to say.
A bug under a microscope.
Franchise, plausibly implies pluralS. Big PharmaS. PaymentS. PlatformS. DunnoS. Thanks.
Maybe he means, like in PPHM/CDMO, Millennium Management, for instance, could take a stake. I mean, if you can’t beat em, join em? I have no idea what he means, that being said. I wouldn’t be short, but, I’m not a financial advisor. LC, what do you mean?
…. “They ought to have a big pharma partner lined up…” or, ‘partners’, franchise? I dunno. Or, LC says maybe a buy out. He’s certainly hangin around waiting on something…
Ah. Thanks. Sounds, intriguing…
Someone said something about franchise(s)…
LC, do you ever feel like a bug under a microscope?
Just your opinion…. :)
Does that mean you can get an extra 1.7% on your 9700 shares?
IQ. (For Iq). You’re such a prolific poster, very verbose, loquacious. Yet now, to Basin’s, well, inquiry, no words?
And, ts, what does this mean? Thanks in advance.
Morning, ts.
Right. And don’t forget fear. You know, a common metaphor used is, ‘you’re either on the train, or you’re on the tracks.’ Fear. And so, someone gets on the bus, first. Right? Dominos. Imo. These are not really very brave people. Imo.
Ex, you lend the appearance of being a jack of all trades, if you will; an expert in many disciplines. So, I’ll ask you, do you know whether prosecutors can use pattern and practice investigation to help establish a conspiracy? Learning Curve, feel free to pipe in. I’ve always found PPHM to be fascinating, for example.
You said, “ I'll be waiting for them…”. You’ll be waiting for them?
Interesting.
Great stuff. Did I ever mention I love the Financial Times? Especially the Weekend Edition. I’ll be heading out soon to buy a copy. Will enjoy with pancakes today. Thanks. And thanks to Joe Miller, too. There’s a BIG story here. Best to all patients in need.
Good stuff. Thanks.
Thanks. Reading Hoff is always very interesting.
IQ, I’m not allowed to talk to you. Board doesn’t appreciate. But, just wanted to check in.
Great post, Doc …